Table 3.
Total | AQP4+ | MOG+ | Double- Seronegative |
|
---|---|---|---|---|
Patients with ≥SIE n (%) * | 17/42 (40%) | 11/24 (46%) | 2/8 (25%) | 4/10 (40%) |
SIE (mean number)/year | 0.24 | 0.32 | 0.1 | 0.18 |
Death during SIE, n (%) | 3 (7%) | 3 (12.5%) | 0 (0%) | 0 (0%) |
Type of SIE | ||||
Urinary tract infection | 21 (50%) | 13 (54.2%) | 4 (50%) | 4 (40%) |
Upper respiratory tract infection | 21 (50%) | 10 (41.7%) | 5 (63%) | 6 (60%) |
Pneumonia | 11 (26.2%) | 7 (29.2%) | 2 (25%) | 2 (20%) |
Bacterial skin infection | 11 (26.2%) | 7 (29.2%) | 0 (0%) | 4 (40%) |
Sepsis | 7 (16.7%) | 5 (20.8%) | 0 (0%) | 2 (20%) |
* During the study period, SIE = severe infectious event.